Covenant Partners, LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,093 filers reported holding NOVARTIS A G in Q3 2019. The put-call ratio across all filers is 0.92 and the average weighting 0.4%.

Quarter-by-quarter ownership
Covenant Partners, LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q2 2024$802,922
+10.1%
7,5420.0%0.24%
+14.6%
Q1 2024$729,538
-7.9%
7,542
-3.9%
0.21%
-14.8%
Q4 2023$792,514
-2.0%
7,849
-1.1%
0.25%
-15.0%
Q3 2023$808,667
+0.5%
7,939
-0.5%
0.29%
+1.0%
Q2 2023$804,757
+11.4%
7,975
+1.6%
0.29%
+5.1%
Q1 2023$722,108
-8.0%
7,849
-9.3%
0.28%
-12.3%
Q4 2022$784,728
-1.3%
8,650
-17.3%
0.32%
-18.3%
Q3 2022$795,000
-10.1%
10,4590.0%0.39%
-5.4%
Q2 2022$884,000
-25.7%
10,459
-22.9%
0.41%
-13.7%
Q1 2022$1,190,000
+22.6%
13,561
+22.1%
0.47%
+31.7%
Q4 2021$971,000
-19.9%
11,106
-25.0%
0.36%
-24.4%
Q3 2021$1,212,000
+19.6%
14,815
+33.4%
0.48%
+24.6%
Q2 2021$1,013,000
-17.6%
11,106
-22.8%
0.38%
-22.0%
Q1 2021$1,230,000
-31.7%
14,388
-24.5%
0.49%
-35.7%
Q4 2020$1,800,000
+106.9%
19,057
+90.5%
0.76%
+81.0%
Q3 2020$870,000
+9.7%
10,002
+10.1%
0.42%
+14.4%
Q2 2020$793,000
-9.1%
9,084
-14.1%
0.37%
-20.9%
Q1 2020$872,000
+37.3%
10,581
+57.7%
0.46%
+57.1%
Q4 2019$635,000
-38.9%
6,711
-43.9%
0.30%
-46.4%
Q3 2019$1,040,000
+69.7%
11,967
+78.3%
0.55%
+69.3%
Q2 2019$613,000
-19.4%
6,711
-15.2%
0.33%
-22.9%
Q1 2019$761,000
+46.1%
7,913
+30.3%
0.42%
+69.9%
Q4 2018$521,0006,0730.25%
Other shareholders
NOVARTIS A G shareholders Q3 2019
NameSharesValueWeighting ↓
Martin Investment Management, LLC 318,637$27,960,0007.08%
MANAGED ASSET PORTFOLIOS, LLC 417,183$36,608,0005.02%
SAL Trading, LLC 233,600$20,498,0004.77%
SCHARF INVESTMENTS, LLC 1,340,680$117,662,0003.49%
SAL Trading, LLC 155,783$13,670,0003.18%
First Fiduciary Investment Counsel, Inc. 169,371$14,862,0002.90%
PRENTISS SMITH & CO INC 55,026$4,829,0002.90%
GARLAND CAPITAL MANAGEMENT INC 47,630$4,180,0002.77%
Cullen Capital Management, LLC 3,295,271$289,160,0002.66%
WILKINS INVESTMENT COUNSEL INC 133,880$11,748,0002.65%
View complete list of NOVARTIS A G shareholders